MedTrace Logo

The Effect of Lumify™ Eyedrops on Eyelid Position

NCT03782701 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2021-06-14

Study results available
· View outcomes & findings →

Summary

The purpose of the research is to see if Lumify™ has an effect on eyelid position.

Conditions

  • Eyelid Droop

Interventions

DRUG

Brimonidine tartrate ophthalmic solution 0.025%

One time dosing of brimonidine tartrate ophthalmic solution 0.025% (1 drop applied to ocular surface)

OTHER

Sterile balanced saline solution

One time dosing of sterile balanced saline solution (1 drop applied to ocular surface)

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Wendy W Lee, MD, MS · Bascom Palmer Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-18
Primary Completion
2020-04-01
Completion
2020-04-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03782701 on ClinicalTrials.gov